Abstract
The aim of this study was to analyze medical outcomes, including risks for complications and mortality, in 332 adult patients hospitalized for cellulitis. The infection was documented microbiologically in 128 cases (39%). Staphylococcus aureus (46 cases) and Streptococcus pyogenes (22 cases) were the most frequent causative pathogens. Overall, 63 patients (19%) were discharged early (≤4 days) and 166 patients (50%) were hospitalized for more than 4 days without developing any complications. One hundred three patients (31%) had one or more complications or died. Of these, 78 required surgical debridement, 10 required plastic surgery, 7 underwent amputation, and 15 had shock on presentation. When comparing the three study groups (patients discharged early, patients hospitalized for ≤4 days without complications, and patients who developed 1 or more complication or who died), patients who were discharged early (low risk) were more frequently female and were less likely to have multiple comorbid conditions, hypoalbuminemia, renal insufficiency, and/or cutaneous necrosis at presentation. Overall mortality (<30 days) was 5% (16/332 patients). Factors associated with death were male sex, presence of multiple comorbid conditions, congestive heart failure, morbid obesity, hypoalbuminemia, renal insufficiency, shock, and Pseudomonas aeruginosa cellulitis. These findings can be used to stratify patients with acute cellulitis according to risks for complications and mortality and may be helpful when deciding the most appropriate means of care, i.e. outpatient treatment or hospitalization.
Similar content being viewed by others
References
Bisno AL, Stevens DL (1996) Streptococcal infections of skin and soft tissues. N Engl J Med 334:240–245
Baddour LM (2000) Cellulitis syndromes: an update. Int J Antimicrob Agents 14:113–116
Baddour LM, Bisno AL (1982) Recurrent cellulitis after saphenous venectomy for coronary bypass surgery. Ann Intern Med 97:493–496
Kremer M, Zuckerman R, Avraham Z, Raz R (1991) Long-term antimicrobial therapy in the prevention of recurrent soft-tissue infections. J Infect 22:37–40
Wang JH, Liu YC, Cheng DL, Yen MY, Chen YS, Wang JH, Wann SR, Lin HH (1997) Role of benzathine penicillin G in prophylaxis for recurrent streptococcal cellulitis of the lower legs. Clin Infect Dis 25:685–689
Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, Schlievert PM, Kaplan E (1989) Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 321:1–7
Stevens DL (1992) Invasive group A streptococcus infections. Clin Infect Dis 14:2–11
Schwartz B, Elliott JA, Butler JC, Simon PA, Jameson BL, Welch GE, Facklam RR (1992) Clusters of invasive group A streptococcal infections in family, hospital, and nursing home settings. Clin Infect Dis 15:277–284
Bisno AL, Cockerill FR, Bermudez CT (2000) The initial outpatient-physician encounter in group A streptococcal necrotizing fasciitis. Clin Infect Dis 31:607–608
Sylvetsky N, Raveh D, Schlesinger Y, Rudensky B, Yinnon AM (2002) Bacteremia due to beta-hemolytic Streptococcus group G: increasing incidence and clinical characteristics of patients. Am J Med 112:622–626
Kusne S, Eibling DE, Yu VL, Fitz D, Johnson JT, Kahl LE, Ellis LD (1988) Gangrenous cellulitis associated with gram-negative bacilli in pancytopenic patients: dilemma with respect to effective therapy. Am J Med 85:490–494
Paterson DL, Gruttadauria S, Lauro A, Scott V, Marino IR (2001) Spontaneous gram-negative cellulitis in a liver transplant recipient. Infection 29:345–347
Williams DN, Rehm SJ, Tice AD, Bradley JS, Kind AC, Craig WA (1997) Practice guidelines for community-based parenteral anti-infective therapy. ISDA Practice Guidelines Committee. Clin Infect Dis 25:787–801
Dalovisio JR, Juneau J, Baumgarten K, Kateiva J (2000) Financial impact of a home intravenous antibiotic program on a Medicare managed care program. Clin Infect Dis 30:639–642
Dupuy A, Benchikhi H, Roujeau JC, Bernard P, Vaillant L, Chosidow O, Sassolas B, Guillaume JC, Grobb JJ, Bastuji-Garin S (1999) Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ 318:1591–1594
Brewer VH, Hahn KA, Rohrbach BW, Bell JL, Baddour LM (2000) Risk factor analysis for breast cellulitis complicating breast conservation therapy. Clin Infect Dis 31:654–659
Brook I, Frazier EH (1995) Clinical features and aerobic and anaerobic microbiological characteristics of cellulitis. Arch Surg 130:786–792
Semel JD, Goldin H (1996) Association of athlete's foot with cellulitis of the lower extremities: diagnostic value of bacterial cultures of ipsilateral interdigital space samples. Clin Infect Dis 23:1162–1164
Perl B, Gottehrer P, Raveh D, Schlesinger Y, Rudensky B, Yinnon AM (1999) Cost-effectiveness of blood cultures for adult patients with cellulitis. Clin Infect Dis 29:1483–1488
Schmid MR, Kossmann T, Duewell S (1998) Differentiation of necrotizing fasciitis and cellulitis using MR imaging. AJR Am J Roentgenol 170:615–620
The working group on severe streptococcal infections (1993) Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA 269:390–391
Uman SJ, Kunin CM (1975) Needle aspiration in the diagnosis of soft tissue infections. Arch Intern Med 185:959–961
Sachs MK (1990) The optimum use of needle aspiration in the bacteriologic diagnosis of cellulitis in adults. Arch Intern Med 150:1907–1912
Koutkia P, Mylonakis E, Boyce J (1999) Cellulitis: evaluation of possible predisposing factors in hospitalized patients. Diagn Microbiol Infect Dis 34:325–327
Aly AA, Roberts NM, Seipol KS, MacLellan DG (1996) Case survey of management of cellulitis in a tertiary teaching hospital. MJA 165:553–556
Hook EW III, Hooton TM, Horton CA, Coyle MB, Ramsey PG, Turck M (1986) Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med 146:295–297
Sigurdsson AF, Gudmundsson S (1989) The etiology of bacterial cellulitis as determined by fine-needle aspiration. Scand J Infect Dis 21:537–542
Sachs MK (1991) Cutaneous cellulitis. Arch Dermatol 127:493–496
Guberman D, Gilead LT, Zlotogorski A, Schamroth J (1999) Bullous erysipelas: a retrospective study of 26 patients. J Am Acad Dermatol 41:733–737
Corredoira JM, Ariza J, Pallarés R, Carratalà J, Viladrich PF, Rufí G, Verdaguer R, Gudiol F (1994) Gram-negative bacillary cellulitis in patients with hepatic cirrhosis. Eur J Clin Microbiol Infect Dis 13:19–24
Tice AD (1995) Experience with a physician-directed, clinic-based program for outpatient parenteral antibiotic therapy in the USA. Eur J Clin Microbiol Infect Dis 14:655–661
Francioli P, Etienne J, Hoigne R, Thys J-P, Gerber A (1992) Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks: efficacy and outpatient treatment feasibility. JAMA 267:264–267
Talcott JA, Whalen A, Clark J, Reiker PR, Finberg R (1994) Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule. J Clin Oncol 12:107–114
Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336:243–250
Rosón B, Carratalà J, Dorca J, Casanova A, Manresa F, Gudiol F (2001) Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria. Clin Infect Dis 33:158–165
Sharkawy A, Low DE, Saginur R, Gregson D, Schwartz B, Jessamine P, Green K, McGeer A (2002) Severe group A streptococcal soft-tissue infections in Ontario: 1992–1996. Clin Infect Dis 34:454–460
Stevens DL (1995) Streptococcal toxic shock syndrome: spectrum of disease, pathogenesis and new concepts in treatment. Emerg Infect Dis 1:69–78
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Carratalà, J., Rosón, B., Fernández-Sabé, N. et al. Factors Associated with Complications and Mortality in Adult Patients Hospitalized for Infectious Cellulitis. Eur J Clin Microbiol Infect Dis 22, 151–157 (2003). https://doi.org/10.1007/s10096-003-0902-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-003-0902-x